Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development expense	$ 86,129	$ 51,054
General and administrative	37,352	18,663
Total operating expenses	123,481	69,717
Loss from operations	(123,481)	(69,717)
Other income (expense)
Interest income	2,764	23
Service fee income from related party		181
Change in fair value of derivative liability		(6,231)
Total other income (expense)	2,764	(6,027)
Loss from equity method investment in joint venture	0	(231)
Net loss and comprehensive loss	$ (120,717)	$ (75,975)
Net loss per common share - basic	$ (3.65)	$ (8.95)
Net loss per common share - diluted	$ (3.65)	$ (8.95)
Weighted average shares of common stock outstanding - basic	33,033,081	8,493,273
Weighted Average Number of Shares Outstanding, Diluted	33,033,081	8,493,273